SPONSOR
European Organisation for Research and Treatment of Cancer - EORTC
Total Trials
3
Recruiting
3
Phases
Phase 3, Phase 2
Conditions studied: Retroperitoneal SarcomaLiposarcomaLeiomyosarcomaBreast CancerProstate CancerNSCLCColorectal CancerOligometastatic DiseaseRecurrent Meningioma
European Organisation for Research and Treatment of Cancer - EORTC is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma, Breast Cancer.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — European Organisation for Research and Treatment of Cancer - EORTC
How many clinical trials has European Organisation for Research and Treatment of Cancer - EORTC sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by European Organisation for Research and Treatment of Cancer - EORTC, of which 3 are actively recruiting participants. These trials cover conditions including Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does European Organisation for Research and Treatment of Cancer - EORTC research focus on?
European Organisation for Research and Treatment of Cancer - EORTC clinical trials span Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma, Breast Cancer, Prostate Cancer, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a European Organisation for Research and Treatment of Cancer - EORTC clinical trial?
To participate in a European Organisation for Research and Treatment of Cancer - EORTC trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all European Organisation for Research and Treatment of Cancer - EORTC trials with current recruitment status updated daily.
Clinical Trials by European Organisation for Research and Treatment of Cancer - EORTC
NCT04031677 Phase 3
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Retroperitoneal Sarcoma
NCT06462963
Recruiting
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
Breast Cancer
NCT06326190 Phase 2
Recruiting
177Lu-DOTATATE for Recurrent Meningioma
Recurrent Meningioma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology